Status: Recruiting
Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)
The purpose of this study is to determine if intensive lowering of systolic blood pressure (SBP), using FDA approved medications (antihypertensive), reduces Alzheimer's Disease pathology (i.e., excessive brain amyloid and tau protein deposition) in older adults at high risk for memory decline or dementia.
Participants needed: 180
Trial details
Phase: Phase 2Age: 60-85Biological sex: AllType: InterventionalSponsor: Rong ZhangUpdated: Aug 5, 2025Locations: 1
Eligibility criteria
Age 60-85, all races/ethnicities, and both sexes are eligible; [+5]
Clinically documented history of stroke, focal neurological signs or other major... [+24]